Yahoo
ASX - Delayed Quote AUD

Telix Pharmaceuticals Limited (TLX.AX)

13.13 -0.35 (-2.60%)
At close: October 30 at 4:13:31 PM GMT+11
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
890,785
803,794
516,551
332,978
108,913.29
Cost of Revenue
412,621
377,356
180,388
123,445
44,335.14
Gross Profit
478,164
426,438
336,163
209,533
64,578.15
Operating Expense
430,819
408,385
280,579
174,568
115,053.68
Operating Income
47,345
18,053
55,584
34,965
-50,475.53
Net Non Operating Interest Income Expense
-36,930
-35,042
-17,262
-8,414
-4,552.57
Other Income Expense
18,403
11,723
-407
-23,957
-12,064.44
Pretax Income
28,818
-5,266
37,915
2,594
-98,622
Tax Provision
-4,679
1,859
4,230
-1,614
5,457
Net Income Common Stockholders
33,497
-7,125
33,685
4,208
-104,079
Diluted NI Available to Com Stockholders
33,497
-7,125
33,685
4,208
-104,079
Basic EPS
0.10
-0.02
0.10
0.01
-0.34
Diluted EPS
0.10
-0.02
0.10
0.01
-0.23
Basic Average Shares
323,177.86
319,181
331,226
319,181
310,644.17
Diluted Average Shares
327,706.86
323,710
--
319,181
310,644.17
Total Operating Income as Reported
65,748
29,776
55,177
11,008
-91,930
Rent Expense Supplemental
--
4,550
2,835
2,509
1,426.59
Total Expenses
843,440
785,741
460,967
298,013
159,388.82
Net Income from Continuing & Discontinued Operation
33,497
-7,125
33,685
4,208
-70,804.93
Normalized Income
27,203.60
-14,467.30
34,312.23
20,987.70
-62,316.49
Interest Income
4,484
5,826
7,180
671
1
Interest Expense
43,763
40,416
24,150
8,943
4,496.78
Net Interest Income
-36,930
-35,042
-17,262
-8,414
-6,692
EBIT
72,581
35,150
62,065
11,537
-62,595.75
EBITDA
72,581
35,150
62,065
11,537
-62,595.75
Reconciled Cost of Revenue
412,621
377,356
180,388
123,445
44,335.14
Reconciled Depreciation
--
--
--
6,743
3,659.33
Net Income from Continuing Operation Net Minority Interest
33,497
-7,125
33,685
4,208
-70,804.93
Total Unusual Items Excluding Goodwill
10,489
10,489
-706
-23,971
-12,126.35
Total Unusual Items
10,489
10,489
-706
-23,971
-12,126.35
Normalized EBITDA
62,092
24,661
62,771
35,508
-50,469.41
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
4,195.60
3,146.70
-78.77
-7,191.30
-3,637.90
12/31/2022 - 11/14/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: